CTLA4 and myeloid sarcoma: In addition, analyzing the peripheral blood mononuclear cells (PBMC) of an MS patient with a very rapidly progressing disease, the authors found that the expression of CTLA-4 was raised on both T-cell subsets at all the times evaluated [80].